68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Summary

The primary objective of the study is to evaluate 68Ga-DOTA TATE PET/CT for staging and monitoring response to chemotherapy in patients with carcinoid, neuroendocrine tumors, medullary thyroid cancer and other cancers expressing somatostatin receptors.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications